Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 6;11(12):1764.
doi: 10.3390/antibiotics11121764.

In Vitro Study on Green Propolis as a Potential Ingredient of Oral Health Care Products

Affiliations

In Vitro Study on Green Propolis as a Potential Ingredient of Oral Health Care Products

Achille Coluccia et al. Antibiotics (Basel). .

Abstract

Propolis is increasingly being discussed as an alternative to commonly used antiseptics. This in vitro study focused on the ethanolic extract of green Brazilian propolis (EEPg) as an additive in an oral health care product. We investigated (i) a potential inflammation-modulation activity of EEPg when a periodontal or Candida biofilm was exposed to monocytic (MONO-MAC-6) cells, (ii) the adhesion of oral pathogens to gingival keratinocytes and (iii) the antimicrobial and antibiofilm effect of different toothpaste formulations. EEPg decreased the levels of interleukin (IL)-1β and increased IL-10 in MONO-MAC cells challenged with a periodontal biofilm. In contact with TIGK cells, EEPg reduced the numbers of adherent Porphyromonas gingivalis to 0.5% but did not affect the adhesion of Candida albicans. The frequent brushing of a cariogenic biofilm with a toothpaste supplemented with EEPg reduced the surface microhardness loss of enamel specimens. Mixing an experimental erythritol toothpaste with 25 and 50 mg/mL of EEPg confirmed the antibacterial activity of EEPg against oral bacteria and particularly inhibited periodontal biofilm formation. The suggested toothpaste formulations seem to have potential in the prevention of caries, gingivitis and periodontitis and should be evaluated in further in vitro research and in clinical trials.

Keywords: Brazilian green propolis; biofilm; monocytic cells; toothpaste.

PubMed Disclaimer

Conflict of interest statement

A.L. is consultant at EMS, Nyon, Switzerland. The other authors declare no conflicts of interest. The funder had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Figure 1
Figure 1
Released interleukin(IL)-1β (a,c,e) and IL-10 (b,d,f) from MONO-MAC-6 cells after being exposed to ethanolic extract of green propolis (EEPg) or ethanol without (a,b) and with a Candida biofilm (c,d) or with a periodontal biofilm (e,f) for 2, 4 and 8 h. Presented are mean and SD, */** p < 0.05/p < 0.01 vs. control of the respective time and assay. ΠΠ p < 0.01 vs. MONO-MAC-6 cells without biofilm at the respective time.
Figure 2
Figure 2
Monocytic (MONO-MAC-6-cells) mRNA expression of interleukin(IL)-1β (a) and IL-10 (b) after being exposed to 1.25 mg/mL ethanolic extract of green propolis (EEPg) and/or a periodontal biofilm for 30 min. Presented are mean and SD, ** p < 0.01 vs. control (The MONO-MAC-6 cells were tested for any cytotoxic reaction. Increased vitality of cells was found 2 h and 4 h after exposing them to 1.25 mg/mL or 2.5 mg/mL propolis; no difference existed after 8 h).
Figure 3
Figure 3
Adhering (incl. invaded) Candida albicans (colony forming units = cfu; mean and SD) to epithelial cells (a) in the presence of ethanolic extract of green propolis (EEPg) and formation of hyphae after being exposed to 2.5 mg/mL EEPg (b). Presented are mean and SD, */** p < 0.05/p < 0.01 vs. control.
Figure 4
Figure 4
Adhering (incl. invaded) Porphyromonas gingivalis (colony forming units = cfu; mean and SD) to epithelial cells in the presence of ethanolic extract of green propolis (EEPg). Presented are mean and SD, ** p < 0.01 vs. control.
Figure 5
Figure 5
Bacterial counts (colony forming units = cfu; mean and SD) present in the biofilms (a), enamel surface microhardness (SMH) loss (b) of the samples in percent (mean and SD) after 14 days of exchange of media twice daily and daily brushing of the enamel specimens with slurries of a commercially available toothpaste (TPcom) without and with added 50 mg/mL ethanolic extract of green propolis (EEPg). Presented are mean and SD, */** p < 0.05/p < 0.01 vs. control.
Figure 6
Figure 6
Activity of the ethanolic extracts of green propolis (EEPg, 25 mg/mL and 50 mg/mL), erythritol (Ery) and different toothpaste formulations (erythritol toothpaste (EryTP) without and with 25 mg/mL or 50 mg/mL EEPg, commercially available TP (TPcom)) on colony forming units (cfu); (a,b), and metabolic activity (c) in a formed two-species biofilm after 2 h (a) and 6 h (b,c). Presented are mean and SD, */** p < 0.05/p < 0.01 vs. control.
Figure 7
Figure 7
Activity of the ethanolic extracts of green propolis (EEPg, 25 mg/mL and 50 mg/mL), erythritol (Ery) and different toothpaste formulations (erythritol toothpaste (EryTP) without and with 25 mg/mL or 50 mg/mL EEPg, commercially available TP (TPcom)) on colony forming units (cfu); (a,b), and metabolic activity (c) in a formed cariogenic biofilm after 6 h (a) and 24 h (b,c). Presented are mean and SD, ** p < 0.01 vs. control.
Figure 8
Figure 8
Activity of the ethanolic extracts of green propolis (EEPg, 25 mg/mL and 50 mg/mL), erythritol (Ery) and different toothpaste formulations (erythritol toothpaste (EryTP) without and with 25 mg/mL or 50 mg/mL EEPg, commercially available TP (TPcom) on colony forming units (cfu); (a,b), and metabolic activity (c) in a periodontal biofilm after 6 h (a) and 24 h (b,c). Presented are mean and SD, */** p < 0.05/p < 0.01 vs. control.

Similar articles

Cited by

References

    1. Kasote D., Bankova V., Viljoen A.M. Propolis: Chemical diversity and challenges in quality control. Phytochem. Rev. 2022;21:1887–1911. doi: 10.1007/s11101-022-09816-1. - DOI - PMC - PubMed
    1. Przybyłek I., Karpiński T.M. Antibacterial Properties of Propolis. Molecules. 2019;24:2047. doi: 10.3390/molecules24112047. - DOI - PMC - PubMed
    1. Salatino A. Perspectives for Uses of Propolis in Therapy against Infectious Diseases. Molecules. 2022;27:4594. doi: 10.3390/molecules27144594. - DOI - PMC - PubMed
    1. Yang J., Pi A., Yan L., Li J., Nan S., Zhang J., Hao Y. Research Progress on Therapeutic Effect and Mechanism of Propolis on Wound Healing. Evidence-Based Complement. Altern. Med. 2022;2022:5798941. doi: 10.1155/2022/5798941. - DOI - PMC - PubMed
    1. González-Serrano J., López-Pintor R.M., Serrano J., Torres J., Hernández G., Sanz M. Short-term efficacy of a gel containing propolis extract, nanovitamin C and nanovitamin E on peri-implant mucositis: A double-blind, randomized, clinical trial. J. Periodontal Res. 2021;56:897–906. doi: 10.1111/jre.12886. - DOI - PubMed